Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update
Tóm tắt
Từ khóa
Tài liệu tham khảo
Shiha G, Sarin SK, Ibrahim AE, Omata M, Kumar A, Lesmana LA, et al. Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 2009;3:323–333
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–926
Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008;336:1106–1110
Mulherin SA, Miller WC. Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med 2002;137:598–602
Poynard T, Ngo Y, Perazzo H, Munteanu M, Lebray P, Moussalli J, et al. Prognostic value of liver fibrosis biomarkers: a meta-analysis. Gastroenterol Hepatol (NY) 2011;7:445–454
Guha IN, Rosenberg WM. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities. Clin Liver Dis 2008;12:883–900.
Goehring C, Goehring C1, Perrier A, Morabia A. Spectrum bias: a quantitative and graphical analysis of the variability of medical diagnostic test performance. Stat Med 2004;23:125–135
Poynard T, Halfon P, Castera L, Munteanu M, Imbert-Bismut F, Ratziu V, et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin chem 2007;53:1615–1622
Grigorescu M. Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis 2006;15:149–159
Scott DA, Netchvolodoff CV, Bacon BR. Delayed subcapsular hematoma after percutaneous liver biopsy is a manifestation of warfarin toxicity. Am J Gastroenterol 1991;86:503–505
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009;49:1017–1044
Judmaier G, Prior C, Klimpfinger M, Bernklau E, Vogel W, Dietze O, et al. Is percutaneous liver biopsy using the ‘Tru-Cut’ ‘(Travenol) needle superior to Menghini puncture? Z Gastroenterol 1989;27:657–661
Colombo M, Del Ninno E, de Franchis R, De Fazio C, Festorazzi S, Ronchi G, et al. Ultrasound assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. Gastroenterology 1988;95:487–489
Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB, et al. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996;23:1079–1083
McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396–1400
Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A oumadiner retrospective study on 68,276 biopsies. J Hepatol 1986;2:165–173
Tobin MV, Gilmore IT. Plugged liver biopsy in patients with impaired coagulation. Dig Dis Sci 1989;34:13–15
Bialecki ES, Ezenekwe AM, Brunt EM, Collins BT, Ponder TB, Bieneman BK, et al. Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006;4:361–368
Tung WC, Huang YJ, Leung SW, Kuo FY, Tung HD, Wang JH, et al. Incidence of needle tract seeding and responses of soft tissue metastasis by hepatocellular carcinoma post-radiotherapy. Liver Int 2007;27:192–200
Khuroo MS, Wani NA, Javid G, Khan BA, Yattoo GN, Shah AH, et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med 1997;337:881–887
Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981;26:388–393
Trotter JF, Olson J, Lefkowitz J, Smith AD, Arjal R, Kenison J. Changes in international normalised ratio (INR) and model for end-stage liver disease (MELD) based on selection of clinical laboratory. Am J Transpl 2007;7:1624–1628
Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 2006;44:1039–1046
Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006;46:1279–1285
Tripodi A, Chantarangkul V, Primignani M, Fabris F, Dell’Era A, Sei C, et al. The international normalised ratio calibrated for cirrhosis [INR- (liver)] normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology 2007;46:520–527
Saxena P, Bihari C, Rastogi A, Agarwal S, Anand L, Sarin SK. Sonoclot signature analysis in patients with liver disease and its correlation with conventional coagulation studies. Adv Hematol 2013;2013:237351
van Leeuwen DJ, Wilson L, Crowe DR. Liver biopsy in the mid-1990s: questions and answers. Semin Liver Dis 1995;15:340–359
Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993;118:96–98
Van Thiel DH, Gavaler JS, Wright H, Tzakis A. Liver biopsy. Its safety and complications as seen at a liver transplant center. Transplantation 1993;55:1087–1090
Kalambokis G, Manousou P, Vibhakorn S, Marelli L, Cholongitas E, Senzolo M, et al. Transjugular liver biopsy: indications, adequacy, quality of specimens, and complications: a systematic review. J Hepatol 2007;47:284–294
Miraglia R, Luca A, Gruttadauria S, Minervini MI, Vizzini G, Arcadipane A, et al. Contribution of transjugular liver biopsy in patients with the clinical presentation of acute liver failure. Cardiovasc Intervent Radiol 2006;29:1008–1010
Azoulay D, Raccuia JS, Roche B, Reynes M, Bismuth H. The value of early transjugular liver biopsy after liver transplantation. Transplantation 1996;61:406–409
Beckmann MG, Bahr MJ, Hadem J, Bredt M, Wedemeyer H, Schneider AS, et al. Clinical relevance of transjugular liver biopsy in comparison with Percutaneous and laparoscopic liver biopsy. Gastroenterol Res Pract 2009;94701428
Ble M, Procopet B, Miquel R, Hernandez-Gea V, García-Pagán JC. Transjugular liver biopsy. Clin Liver Dis 2014;18:767–778
Li FQ, Ko GY, Sung KB, Gwon DI, Ko HK, Kim JW, et al. Transfemoral liver biopsy using a Quick-Core biopsy needle system in living donor liver transplantation recipients. Liver Transpl 2014;20:1178–1184
Clark TW, McCann JW, Salsamendi J, Dowd MF, Hajdu CH. Optimizing needle direction during transjugular liver biopsy provides superior biopsy specimens. Cardiovasc Intervent Radiol 2014;37:1540–1545
Denzer U, Arnoldy A, Kanzler S, Galle PR, Dienes HP, Lohse AW. Prospective randomized comparison of mini-laparoscopy and Percutaneous liver biopsy: diagnosis of cirrhosis and complications. J Clin Gastroenterol 2007;41:103–110
Steele K, Schweitzer MA, Lyn-Sue J, Kantsevoy SV. Flexible transgastric peritoneoscopy and liver biopsy: a feasibility study in human beings (with videos). Gastrointest Endosc 2008;68:61–66
The Royal College of Pathologists. Tissue pathways for liver biopsies for the investigation of medical disease and for focal lesions. The Royal College of Pathologists, 2008
Bedossa P. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449–1457
Colloredo G1, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39:239–244
Cholongitas E, Senzolo M, Standish R, Marelli L, Quaglia A, Patch D, et al. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol 2006;125:710–721
Cholongitas E, Quaglia A, Samonakis D, Senzolo M, Triantos C, Patch D, et al. Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut 2006;55:1789–1794
Riley TR 3rd, Ruggiero FM. The effect of processing on liver biopsy core size. Dig Dis Sci 2008;53:2775–2777
Bull HJ, Gilmore IT, Bradley RD, Marigold JH, Thompson RP. Experience with transjugular liver biopsy. Gut 1983;24:1057–1060
Hall AR, Tsochatzis E, Morris R, Burroughs AK, Dhillon AP. Sample size requirement for digital image analysis of collagen proportionate area in cirrhotic livers. Histopathology 2013;62:421–430
Scheuer PJ. Liver biopsy size matters in chronic hepatitis: bigger is better. Hepatology 2003;38:1356–1358
Guido M, Mangia A, Faa G; Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Chronic viral hepatitis: the histology report. Dig Liver Dis 2011;43(Suppl 4):S331–S343
De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, et al. A classification of chronic hepatitis. Lancet 1968;2:626–628
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431–435
Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696–699
Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289–293
Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006;55: 569–578
Rousselet MC, Michalak S, Dupré F, Croué A, Bedossa P, Saint-André JP, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005;41:257–264
Gailhouste L, Le Grand Y, Odin C, Guyader D, Turlin B, Ezan F, et al. Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis. J Hepatol 2010;52:398–406
Goodman ZD, Stoddard AM, Bonkovsky HL, Fontana RJ, Ghany MG, Morgan TR, et al. Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial. Hepatology 2009;50:1738–1749
O’Brien MJ1, Keating NM, Elderiny S, Cerda S, Keaveny AP, Afdhal NH, et al. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol 2000;114:712–718
Maduli E, Andorno S, Rigamonti C, Capelli F, Morelli S, Colombi S, et al. Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method. Ann Ital Med Int 2002;17:242–247
Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H, et al. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. J Hepatol 1998;28:439–446
Xu S, Wang Y, Tai DC, Wang S, Cheng CL, Peng Q, et al. qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients. J Hepatol 2014;61:260–269
Isse K, Grama K, Abbott IM, Lesniak A, Lunz JG, Lee WM, et al. Adding value to liver (and allograft) biopsy evaluation using a combination of multiplex quantum dot immunostaining, high-resolution whole-slide digital imaging, and automated image analysis. Clin Liver Dis 2010;14:669–685
Molleken C, Mölleken C, Sitek B, Henkel C, Poschmann G, Sipos B, et al. Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology 2009;49:1257–1266
Werling K, Szentirmay Z, Szepesi A, Schaff Z, Szalay F, Szabó Z, et al. Hepatocyte proliferation and cell cycle phase fractions in chronic viral hepatitis C by image analysis method. Eur J Gastroenterol Hepatol 2010;13:489–493
Shiha GE, Zalata KR, Abdalla AF, Mohamed MK. Immunohistochemical identification of HCV target antigen in paraffin-embedded liver tissue: reproducibility and staining patterns. Liver Int 2005;25:254–260
Khalid SS, Hamid S, Siddiqui AA, Qureshi A, Qureshi N. Gene profiling of early and advanced liver disease in chronic hepatitis C patients. Hepatol Int 2011;5:782–788
Furuta K, Sato S, Yamauchi T, Ozawa T, Harada M, Kakumu S. Intrahepatic gene expression profiles in chronic hepatitis B and autoimmune liver disease. J Gastroenterol 2008;43:866–874
Mas V1, Maluf D, Archer KJ, Potter A, Suh J, Gehrau R, et al. Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation. Liver Transpl 2011;17:824–835
Tripodo C, Petta S, Guarnotta C, Pipitone R, Cabibi D, Colombo MP, et al. Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. Antivir Ther 2012;17:111–118
Xu R, Zhang Z, Wang FS. Liver fibrosis: mechanisms of immune-mediated liver injury. Cell Mol Immunol 2012;9:296–301
Rojkind, Giambrone MA, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979;76:710–719
Gressner AM, Krull N, Bachem MG. Bachem, Regulation of proteoglycan expression in fibrotic liver and cultured fat storing cells. Pathol Res Pract 1994;190:864–882
Arthur MJ. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis, Am J Physiol Gastrointest Liver Physiol 2000;279:G245–G249
Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests, Clin Chim Acta 2007;38:107–113
Veidal SS, Bay-Jensen AC, Tougas G, Karsdal MA, Vainer B. Serum markers of liver fibrosis: combining the BIPED classification and the neo-epitope approach in the development of new biomarkers. Dis Markers 2010;28:15–28
Hayasaka A, Koch J, Schuppan D, Maddrey WC, Hahn EG. The serum concentrations of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the alpha 1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesis. J Hepatol 1991;13:328–338
Xie Q, Zhou X, Huang P, Wei J, Wang W, Zheng S. The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: ameta-analysis. PLoS One 2014;9:e92772
Innes HA, McDonald SA, Dillon JF, Allen S, Hayes PC, Goldberg D, et al. Towards a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes. Hepatology 2015;62:355–364
Tamaki N, Kurosaki M, Kuno A, Korenaga M, Togayachi A, Gotoh M, et al. Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients. Hepatol Res 2015;45:E82–E88
Tamaki N, Kurosaki M, Izumi N. Noninvasive estimation of liver fibrosis and hepatocellular carcinoma development using WFA(+)-M2BP in chronic hepatitis C patients. Rinsho Byori 2015;63:1039–1043
Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, et al. Biomarkers of liver fibrosis. Adv Clin chem 2008;46:131–160
Udell JA, Wang CS, Tinmouth J, FitzGerald JM, Ayas NT, Simel DL, et al. Does this patient with liver disease have cirrhosis? JAMA 2012;307:832–842
Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002;36(5 Suppl. 1):S57–S64
Afzal S, Masroor I, Beg M. Evaluation of chronic liver disease: does ultrasound scoring criteria help? Int J Chronic Dis 2013;2013:326231
Wilson SR, Withers CE. The Liver. In Rumack CM, Wilson SR, Charboneau JW, Johnson JAM (eds). Diagnostic Ultrasound, 3rd Edition. Philadelphia: Mosby, 2005
Giorgio A, Amoroso P, Lettieri G, Fico P, de Stefano G, Finelli L, et al. Cirrhosis: value of caudate to right lobe ratio in diagnosis with ultrasound. Radiology 1986;161:443–445
Taylor KJ, Riely CA, Hammers L, Flax S, Weltin G, Garcia-Tsao G, et al. Quantitative ultrasound attenuation in normal liver and in patients with diffuse liver disease. Importance of fat. Radiology 1986;160:65–71
Murakami T, Kuroda C, Marukawa T, Harada K, Wakasa K, Sakurai M, et al. Regenerating nodules in hepatic cirrhosis. MR findings with pathologic correlation. AJR Am J Rontgen 1990;155:1227–1231
Shen L, Li JQ, Zeng MD, Lu LG, Fan ST, Bao H. Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis. World J Gastroenterol 2006;12:1292–1295
Choong CC, Venkatesh SK, Siew EP. Accuracy of routine clinical ultrasound for staging of liver fibrosis. J Clin Imaging Sci 2012;2:58
Berzigotti A, Piscaglia F, EFSUMB Education and Professional Standards Committee. Ultrasound in portal hypertension–part 2–and EFSUMB recommendations for the performance and reporting of ultrasound Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis examinations in portal hypertension. Ultraschall Med 2012;33:8–32
Bouakaz A, de Jong N. WFUMB Safety symposium on echo-contrast agents: nature and types of ultrasound contrast agents. Ultrasound Med Biol 2007;33:187–196
Maruyama H, Ishibashi H, Takahashi M, Imazeki F, Yokosuka O. Effect of signal intensity from the accumulated microbubbles in the liver for differentiation of idiopathic portal hypertension from liver cirrhosis. Radiology 2009;252:587–594
Fritz GA, Schoellnast H, Deutschmann HA, Wiltgen M, Brader P, Berghold A, et al. Density histogram analysis of unenhanced hepatic computed tomography in patients with diffuse liver diseases. J Comput Assist Tomogr 2006;30:201–205
Colagrande S, Centi N, Galdiero R, Ragozzino A. Transient hepatic intensity differences: part 2, those not associated with focal lesions. AJM Am J Roentgenol 2007;188:160–166
Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJM Am J Roentgenol 2001;176:667–673
Kapanen M, Halavaara J, Häkkinen AM. Comparison of liver perfusion parameters studied with conventional extravascular and experimental intravascular CT contrast agents. Acad Radiol 2007;14:951–958
Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, et al. Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology 2008;51(Suppl 1):17–26
Huber A, Ebner L, Montani M, Semmo N, Roy Choudhury K, Heverhagen J, et al. Computed tomography findings in liver fibrosis and cirrhosis. Swiss Med Wkly 2014;144:w13923
Talwalkar JA, Yin M, Fidler JL, Sanderson SO, Kamath PS, Ehman RL. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology 2008;47:332–342
Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 2006;239:425–437
Wang QB, Zhu H, Liu HL, Zhang B. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology 2012;56:239–247
Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012;61:409–415
Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48–54
Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2007;5:1214–1220
Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960–974
Adebajo CO, Talwalkar JA, Poterucha JJ, Kim WR, Charlton MR. Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis. Liver Transpl 2012;18:323–331
Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010;52:206–210
Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010;5:828–835
Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Beaton M, Levstik M, et al. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol 2012;56:564–270
de Lédinghen V, Wong VW, Vergniol J, Wong GL, Foucher J, Chu SH, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. J Hepatol 2012;56:833–839
Wong VW, Vergniol J, Wong GL, Foucher J, Chan AW, Chermak F, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2012;107:1862–1871
Tapper EB, Cohen EB, Patel K, Bacon B, Gordon S, Lawitz E, et al. Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol 2012;10:932–937
Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M, et al. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008;48:606–613
Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011;54:64–71
Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol 2010;16:966–972
Ochi H, Hirooka M, Koizumi Y, Miyake T, Tokumoto Y, Soga Y, et al. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. Hepatology 2012;56:1271–1278
Singh S, Fujii LL, Murad MH, Wang Z, Asrani SK, Ehman RL, et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013;11:1573–1584
Cescon M, Colecchia A, Cucchetti A, Peri E, Montrone L, Ercolani G, et al. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg 2012;256:706–712
Nguyen-Khac E, Nahon P, Boursier J, Moreno C, Starkel P, Mueller S, et al. Non-invasive diagnosis of liver fibrosis by fibroscan in patients with alcoholic liver disease: a meta-analysis with individual data. J Hepatol 2014;60(Suppl. 1):S34
Corpechot C, Gaouar A, El Naggar A, Kemgang D, Wendum R, Poupon F, et al. Liver stiffness assessed by fibroscan is a major prognostic factor in primary sclerosing cholangitis. J Hepatol 2014;60(Suppl. 1):S34
Friedrich-Rust M, Nierhoff J, Lupsor M, Sporea I, Fierbinteanu-Braticevici C, Strobel D, et al. Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 2012;19:e212–219
Nierhoff J, Chávez Ortiz AA, Herrmann E, Zeuzem S, Friedrich-Rust M. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur Radiol 2013;23:3040–3053
Yap WW, Kirke R, Yoshida EM, Owen D, Harris AC. Non-invasive assessment of liver fibrosis using ARFI with pathological correlation, a prospective study. Ann Hepatol 2013;12:608–615
Bota S, Sporea I, Sirli R, Popescu A, Gradinaru-Tascau O. How useful are ARFI elastography cut-off values proposed by meta-analysis for predicting the significant fibrosis and compensated liver cirrhosis? Med Ultrason 2015;17:200–205
Liu H, Fu J, Hong R, Liu L, Li F. Acoustic radiation force impulse elastography for the non-invasive evaluation of hepatic fibrosis in non-alcoholic fatty liver disease patients: A systematic review & meta-analysis. PLoS One. 2015;10:e0127782
Bota S, Herkner H, Sporea I, Salzl P, Sirli R, Neghina AM, et al. Meta-analysis: ARFI elastography versus transient elastography for theevaluation of liver fibrosis. Liver Int 2013;33:1138–1147
Kobayashi K, Nakao H, Nishiyama T, Lin Y, Kikuchi S, Kobayashi Y, et al. Diagnostic accuracy of real-time tissue elastography for the staging of liver fibrosis: a meta-analysis. Eur Radiol 2015;25:230–238
Muller M, Gennisson JL, Deffieux T, Tanter M, Fink M. Quantitative viscoelasticity mapping of human liver using supersonic shear imaging: preliminary in vivo feasibility study. Ultrasound Med Biol 2009;35:219–229
Sirli R, Bota S, Sporea I, Jurchis A, Popescu A, Gradinaru-Tascău O, et al. Liver stiffness measurements by means of supersonic shear imaging in patients without known liver pathology. Ultrasound Med Biol 2013;39:1362–137
Pinzani M, Pinzani M, Vizzutti F, Arena U, Marra F. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nat Clin Pract Gastroenterol Hepatol 2008;5:95–106
Yoneda M, Thomas E, Sclair SN, Grant TT, Schiff ER. Supersonic shear imaging and transient elastography with the XL probe accurately detect fibrosis in overweight or obese patients with chronic liver disease. Clin Gastroenterol Hepatol 2015;13:1502–1509
Jiang Y, Li GY, Qian LX, Hu XD, Liu D, Liang S, et al. Characterization of the nonlinear elastic properties of soft tissues using the supersonic shear imaging (SSI) technique: inverse method, ex vivo and in vivo experiments. Med Image Anal 2015;20:97–111
Deffieux T, Gennisson JL, Bousquet L, Corouge M, Cosconea S, Amroun D et al. Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography. J Hepatol 2015;62:317–324
Sporea I, Bota S, Jurchis A, Sirli R, Grădinaru-Tascău O, Popescu A, et al. Acoustic radiation force impulse and supersonic shear imaging versus transient elastography for liver fibrosis assessment. Ultrasound Med Biol 201;39:1933–1941
Cassinotto C, Boursier J, de Lédinghen V, Lebigot J, Lapuyade B, Cales P, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 2016;63:1817–1827
Bavu E, Gennisson JL, Couade M, Bercoff J, Mallet V, Fink M, et al. Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients. Ultrasound Med Biol 2011;37:1361–1373
Cassinotto C, Lapuyade B, Mouries A, Hiriart JB, Vergniol J, Gaye D, et al. Noninvasive assessment of liver fibrosis with impulse elastography: comparison of supersonic shear imaging with ARFI and FibroScan®. J Hepatol 2014;61:550–557
Venkatesh SK, Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 2013;37:544–555
Low G, Kruse SA, Lomas DJ. General review of magnetic resonance elastography. World J Radiol 2016;8:59–72
Huwart L, Sempoux C, Vicaut E, Salameh N, Annet L, Danse E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008;135:32–40
Venkatesh SK, Wang G, Lim SG, Wee A. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol 2014;24:70–78
Guo Y, Parthasarathy S, Goyal P, McCarthy RJ, Larson AC, Miller FH. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging 2015;40:818–834
Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Enomoto N, et al. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci 2012;11:291–297
Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011;259:749–756
Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology 2013;268:411–419
Bensamoun SF, Leclerc GE, Debernard L, Cheng X, Robert L, Charleux F, et al. Cutoff values for alcoholic liver fibrosis using magnetic resonance elastography technique. Alcoholism, clinical and experimental research 2013;37:811–817
Russo MW, Galanko JA, Zacks SL, Beavers KL, Fried MW, Shrestha R. Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis C. Am J Transplant 2004;4:1133–1138
Toniutto P, Fabris C, Avellini C, Minisini R, Bitetto D, Rossi E, et al. Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation. World J Gastroenterol 2005;11:5944–5950
Lee SH, Joo DJ, Kim SU, Kim MS, Lee AL, Choi GH, et al. Graft function measured by transient elastography in living donor liver transplantation: preliminary. Transplant Proc 2013;45:3028–3031
Howell JAngus P, Gow P. Hepatitis C recurrence: the Achilles heel of liver transplantation. Transpl Infect Dis 2014;16:1–16
Carlson JJ, Kowdley KV, Sullivan SD, Ramsey SD, Veenstra DL. An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis. J Gastroenterol Hepatol 2009;24:786–791
Agency for Drugs and Techniques in Health (CADTH). Diagnosis and monitoring of liver fibrosis in patients with chronic hepatitis C: a review of the clinical evidence and cost effectiveness. Rapid response report. Summary and Critical Appraisal March 8, 2012
Liu S, Schwarzinger M, Carrat F, Goldhaber-Fiebert JD. Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients. PLoS One 2011;6(12):e26783
García-Jurado L, Oyagüez I, Casado MÁ, Tural C, González-García J, Ortega E, et al. Evaluation of the costs of transient elastography (FibroScan(®)) in the diagnosis of liver fibrosis in HIV patients with hepatitis C virus. Enferm Infec Microbiol Clin 2012;30:294–299
Stevenson M, Lloyd-Jones M, Morgan MY, Wong R. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation. Health Technology Assessment 2012;16:1–174
Canavan C, Eisenburg J, Meng L, Corey K, Hur C. Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK. Dig Dis Sci 2013;58:2691–2704
Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481–488
Pomier-Layrargues G, Kusielewicz D, Willems B, Villeneuve JP, Marleau D, Côté J, et al. Presinusoidal portal hypertension in nonalcoholic cirrhosis. Hepatology 1985;5:415–418
Rector Jr WG. Propranolol for portal hypertension. Evaluation of therapeutic response by direct measurement of portal vein pressure. Arch Intern Med 1985;145:648–650
Valla D, Bercoff E, Menu Y, Bataille C, Lebrec D. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis. Gastroenterology 1984;86:1400–1403
Perello A, Escorsell A, Bru C, Gilabert R, Moitinho E, García-Pagán JC, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 1999;30:1393–1397
Deplano A, Migaleddu V, Pischedda A, Garrucciu G, Gregu G, Multinu C, et al. Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection. Dig Dis Sci 1999;44:155–162
Okuda K, Okuda K, Suzuki K, Musha H, Arimuzu N. Percutaneous transhepatic catheterization of the portal vein for the study of portal hemodynamics and shunts: A preliminary report. Gastroenterology 1977;73:279–284
Keiding S, Vilstrup H. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis again. Scand J Gastroenterol 2002;37:1344
Thalheimer U, Leandro G, Samonakis DN, Triantos CK, Patch D, Burroughs AK. Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients. Dig Liver Dis 2005;37:601–608
Thalheimer U, Mela M, Patch D, Burroughs AK. Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence. Gut 2004;53:143–148
Guha IN, Myers RP, Patel K, Talwalkar JA. Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve? Hepatology 2011;54:1454–1462
Suk KT, Kim DJ, Kim CH, Park SH, Cheong JY, Cho SW, et al. Diagnostic accuracy of hepatic venous pressure gradient measurement in the prediction of stage 1 compensated liver cirrhosis in patients with chronic hepatitis B. Eur J Gastroenterol Hepatol 2013;25:1170–1176
Kumar M, Kumar A, Hissar S, Jain P, Rastogi A, Kumar D, et al. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus. Liver Int 2008;28:690–698
Suk KT, Kim DJ, Kim CH, Park SH, Cheong JY, Cho SW, et al. Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis. Clin Biochem 2012;45:1075–1080
Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007;45:1290–1297
Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008;27:1261–1268
Carrión JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006;12:1791–1798
Sadler MD, Crotty P, Fatovich L, Wilson S, Rabin HR, Myers RP. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis. Can J Gastroenterol Hepatol 2015;29:139–144
Karlas T, Neuschulz M, Oltmanns A, Wirtz H, Keim V, Wiegand J. ARFI and transient elastography for characterization of cystic fibrosis related liver disease: first longitudinal follow-up data in adult patients. J Cyst Fibros 2013;12:826–827
Kitson MT, Kemp WW, Iser DM, Paul E, Wilson JW, Roberts SK. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease. Liver Int 2013;33:698–705
Karlas T, Neuschulz M, Oltmanns A, Güttler A, Petroff D, Wirtz H, et al. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores. PLoS One 2012;7:e42139
Rath T, Menendez KM, Kügler M, Hage L, Wenzel C, Schulz R, et al. TIMP-1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease. Dig Liver Dis 2012;44:780–787
Malbrunot-Wagner AC, Bridoux L, Nousbaum JB, Riou C, Dirou A, Ginies JL, et al. Transient elastography and portal hypertension in pediatric patients with cystic fibrosis Transient elastography and cystic fibrosis. J Cyst Fibros 2011;10:338–342
Wu YM, Xu N, Hu JY, Xu XF, Wu WX, Gao SX, et al. A simple noninvasive index to predict significant liver fibrosis in patients with advanced schistosomiasis japonica. Parasitol Int 2013;62:283-288
Agha A, Abdulhadi MM, Marenco S, Bella A, Alsaudi D, El-Haddad A, et al. Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol 2011;17:307–311
Esmat G, Elsharkawy A, El Akel W, Fouad A, Helal K, Mohamed MK, et al. Fibroscan of chronic HCV patients coinfected with schistosomiasis. Arab J Gastroenterol 2013;14:109–112
Shiha G, Samir W, Soliman R, Elbasiony M, Ahmed N, Helmy A. Transient Elastography (FibroScan) in not useful in the diagnosis of schistosomal hepatic peri-portal fibrosis. (accepted as poster presentation in APASL meeting, Japan, 2016)